Metabolic Complications Precede Alloreactivity and are Characterized by Changes in ST2 Signaling

被引：0
|
作者：
Johnpulle, Romany Anne Nilanthi [1 ]
Paczesny, Sophie [2 ]
Jung, Dae Kwang [3 ]
Daguindau, Etienne [4 ]
Jagasia, Madan H. [3 ]
Savani, Bipin N. [5 ]
Chinratanalab, Wichai [3 ]
Cornell, Robert F. [5 ]
Goodman, Stacey [3 ]
Greer, John [3 ]
Kassim, Adetola A. [3 ]
Sengsayadeth, Salyka [3 ]
Engelhardt, Brian G. [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Med, Nashville, TN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
69
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [1] Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
    Johnpulle, Romany A. N.
    Paczesny, Sophie
    Jung, Dae Kwang
    Daguindau, Etienne
    Jagasia, Madan H.
    Savani, Bipin N.
    Chinratanalab, Wichai
    Cornell, Robert F.
    Goodman, Stacey
    Greer, John P.
    Kassim, Adetola A.
    Sengsayadeth, Salyka
    Byrne, Michael T.
    Engelhardt, Brian G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 529 - 532
  • [2] Metabolic Complications Precede Alloreactivity and are Characterized by Changes in Th1/Th17 Immunity
    Savani, Ujjawal
    Jung, Dae Kwang
    Crowe, James E.
    Abumrad, Naji N.
    Powers, Alvin C.
    Jagasia, Madan
    Cornell, Robert F.
    Goodman, Stacey
    Kassim, Adetola A.
    Culos, Kathryn A.
    Gatwood, Katie S.
    Byrne, Michael T.
    Engelhardt, Brian G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S213 - S214
  • [3] ST2 Signaling in the Tumor Microenvironment
    Chang, Chih-Peng
    Hu, Meng-Hsuan
    Hsiao, Yu-Peng
    Wang, Yi-Ching
    TUMOR MICROENVIRONMENT: THE ROLE OF INTERLEUKINS, PT A, 2020, 1240 : 83 - 93
  • [4] Protective Role of ST2 Signaling in Diabetic Nephropathy
    Sabapathy, Vikram
    Gajula, Sai Kirthana
    Acharya, Saanvi
    Mehkri, Bushra
    Sharma, Rahul
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [5] IL-33/ST2 signaling in liver transplantation
    Tan, Zhongming
    Sun, Beicheng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) : 761 - 763
  • [6] IL-33/ST2 signaling in liver transplantation
    Zhongming Tan
    Beicheng Sun
    Cellular & Molecular Immunology, 2021, 18 : 761 - 763
  • [7] Interleukin-33 and ST2 Signaling in Tumor Microenvironment
    Hong, Jaewoo
    Kim, Soohyun
    Lin, P. Charles
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (01): : 61 - 71
  • [8] ST2/IL-33 signaling in cardiac fibrosis
    Vianello, Elena
    Dozio, Elena
    Tacchini, Lorenza
    Frati, Luigi
    Romanelli, Massimiliano Marco Corsi
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2019, 116
  • [9] Temporal changes of soluble ST2 after cardiovascular interventions
    Willems, Sanne
    Sels, Jan-Willem
    Flier, Suzanne
    Versteeg, Dik
    Buhre, Wolfgang F.
    de Kleijn, Dominique P. V.
    Hoefer, Imo E.
    Pasterkamp, Gerard
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (02) : 113 - 120
  • [10] Soluble ST2 levels for predicting the presence and severity of metabolic syndrome
    Zong, Xiao
    Fan, Qin
    Zhang, Hang
    Yang, Qian
    Xie, Hongyang
    Chen, Qiujing
    Zhang, Ruiyan
    Tao, Rong
    ENDOCRINE CONNECTIONS, 2021, 10 (03): : 336 - 344
12345